Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

DHS SAL 3.0 % — DIN 02231520

SALICYLIC ACID : 3.0 % · SEAFORD PHARMACEUTICALS INC · SHAMPOO · wholesale supply in Canada

Health Canada status: APPROVED

What is DHS SAL?

DHS SAL 3.0 % contains SALICYLIC ACID : 3.0 %. It is listed in the Health Canada Drug Product Database under DIN 02231520, held by SEAFORD PHARMACEUTICALS INC, supplied as SHAMPOO for TOPICAL administration. Health Canada currently lists it as approved, status dated 13-Jun-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.

Is there a generic Others in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

14 holders have a Canadian DIN containing Others, across 18 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
JOHNSON & JOHNSON INC20T/GEL OVERNIGHT DANDRUFF TREATMENT, T/GEL SHAMPOONo marketed DIN
ROUGIER PHARMA DIVISION OF RATIOPHARM INC20CAPILLEX LIQ, CAPILLEX N LIQNo marketed DIN
THOMAS HAIR AND SCALP SPECIALISTS20THOMAS FORMULA NO 17, THOMAS FORMULA NO 96No marketed DIN
YVES ROCHER INC.20BIOCURE: SHAMPOOING ANTIPELLICULAIRE, PHYTUM ANTIPELLICULAIRE SHAMPOOING PURIFIANTNo marketed DIN
BRISTOL-MYERS SQUIBB CANADA10HERBAL ESSENCES ANTI-DANDRUFF SHAMPOONo marketed DIN
CLAIROL, DIVISION PROCTER & GAMBLE INC.10HERBAL ESSENCES ANTI-DANDRUFF SHAMPOONo marketed DIN
GALDERMA CANADA INC10IONIL SHAMPOONo marketed DIN
MATRIX ESSENTIALS INC.10SYSTEME BIOLAGE ANTI-DANDRUFF SHAMPOO - 2%No marketed DIN
MERIT INDUSTRIES INC.10SALSEB MEDICATED SHAMPOONo marketed DIN
PHARMASCIENCE INC10X-SEB PLUS CONDITIONING SHAMPOONo marketed DIN
PIERRE FABRE DERMO-COSMÉTIQUE10MELALEUCA SHAMPOOING ANTIPELLICULAIRE PELLICULES SECHES, CUIR CHEVELU SEC-RENE FURTERERNo marketed DIN
SEAFORD PHARMACEUTICALS INC10DHS SALNo marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label3.0 %
Dosage formSHAMPOO
RouteTOPICAL

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Substance and classification

Active substanceOthers
ATC codeD11AC30
AHFS class84:28.00
Biosimilar biologicNo

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02231520
DIN (unpadded, as printed on some documents)2231520
Brand nameDHS SAL
Generic / active ingredientSALICYLIC ACID : 3.0 %
Market authorization holderSEAFORD PHARMACEUTICALS INC
Health Canada scheduleNON-PRESCRIPTION DRUGS
ATC codeD11AC30
ATC anatomical main groupD — Dermatologicals
ATC therapeutic subgroupD11AC
Current statusAPPROVED
Status date13-Jun-1997
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

0 of 18 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
BIOCURE: SHAMPOOING ANTIPELLICULAIRE1.8 %GELYVES ROCHER INC.CANCELLED POST MARKET02240517
CAPILLEX LIQ3.5 %SHAMPOOROUGIER PHARMA DIVISION OF RATIOPHARM INCCANCELLED POST MARKET00305928
CAPILLEX N LIQ25 %SHAMPOOROUGIER PHARMA DIVISION OF RATIOPHARM INCCANCELLED POST MARKET00305936
DERMAREST PSORIASIS MEDICATED SCALP TREATMENT3 %GELDEL PHARMACEUTICS (CANADA) INC.CANCELLED POST MARKET02243938
HERBAL ESSENCES ANTI-DANDRUFF SHAMPOO3 %LIQUIDBRISTOL-MYERS SQUIBB CANADACANCELLED POST MARKET02239776
HERBAL ESSENCES ANTI-DANDRUFF SHAMPOO2 %LIQUIDCLAIROL, DIVISION PROCTER & GAMBLE INC.CANCELLED POST MARKET02243734
IONIL SHAMPOO.2 %SHAMPOOGALDERMA CANADA INCCANCELLED POST MARKET00899690
MELALEUCA SHAMPOOING ANTIPELLICULAIRE PELLICULES SECHES, CUIR CHEVELU SEC-RENE FURTERER2 G / 100 GSHAMPOOPIERRE FABRE DERMO-COSMÉTIQUECANCELLED POST MARKET02239596
PHYTUM ANTIPELLICULAIRE SHAMPOOING PURIFIANT1.8 %GELYVES ROCHER INC.CANCELLED POST MARKET02247787
SALSEB MEDICATED SHAMPOO2 %SHAMPOOMERIT INDUSTRIES INC.CANCELLED POST MARKET00505757

2 · Same class — other molecules in ATC D11AC

MoleculeCanadian brandsDINsMarketedSourceable
OthersBIOCURE: SHAMPOOING ANTIPELLICULAIRE · CAPILLEX LIQ · CAPILLEX N LIQ · DERMAREST PSORIASIS MEDICATED SCALP TREATMENT · +13 more180Not in Canada
Selenium CompoundsMOISTURIZING SELSUN BLUE · SELSUN BLUE, 2-IN-1 · SELSUN BLUE, NORMAL OILY HAIR30Not in Canada
Povidone-IodineBETADINE SHAMPOO 7.5% · BETADINE SHAMPOO FOR DRY HAIR 4%20Not in Canada
Sulphur CompoundsSEBULEX LIQ · SULFUR 8 MED.ANTIDAND.HAIR & SCALP COND.ORIG20Not in Canada
CetrimideRESDAN DANDRUFF TREATMENT LIQUID 1%10Not in Canada
Medicated ShampoosSOROPON SHAMPOO10Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC D11A

ATC subgroupMoleculesDINsMarketed
D11AXBrimonidine · Deoxycholic Acid · Eflornithine · Finasteride · Hydroquinone · +6 more46688
D11AHAbrocitinib · Alitretinoin · Crisaborole · Delgocitinib · Dupilumab · +5 more2519
D11AFWart And Anti-Corn Preparations331
D11AAAntihidrotics3970

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

How can I get it?

This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.

Ask about availability of DHS SAL

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database. Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02231520. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.